Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder thought to be associated with mitochondrial dysfunction. Loss of function mutations in the putative mitochondrial protein PINK1 (PTEN-induced kinase 1) have been linked to familial forms of PD, but the relation of PINK1 to mammalian mitochondrial function remains unclear. Here, we report that germline deletion of the PINK1 gene in mice significantly impairs mitochondrial functions. Quantitative electron microscopic studies of the striatum in PINK1 −/− mice at 3–4 and 24 months revealed no gross changes in the ultrastructure or the total number of mitochondria, although the number of larger mitochondria is selectively increased. Functional assays showed impaired mitochondrial respiration in the striatum but not in the cerebral cortex at 3–4 months of age, suggesting specificity of this defect for dopaminergic circuitry. Aconitase activity associated with the Krebs cycle is also reduced in the striatum of PINK1 −/− mice. Interestingly, mitochondrial respiration activities in the cerebral cortex are decreased in PINK1 −/− mice at 2 years compared with control mice, indicating that aging can exacerbate mitochondrial dysfunction in these mice. Furthermore, mitochondrial respiration defects can be induced in the cerebral cortex of PINK1 −/− mice by cellular stress, such as exposure to H 2 O 2 or mild heat shock. Together, our findings demonstrate that mammalian PINK1 is important for mitochondrial function and provides critical protection against both intrinsic and environmental stress, suggesting a pathogenic mechanism by which loss of PINK1 may lead to nigrostriatal degeneration in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, when PINK1 is mutated, it loses its function, which means there is no longer any protection against ROS [141].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [141]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, mitophagy deficiency favored by ablation of Prkn (Palacino et al, 2004; Pickrell et al, 2015) or Pink1 (Gautier et al, 2008) sensitizes mice to oxidative stress, while worsening neural damage when combined with mitochondrial dysfunction (mitochondrial DNA [mtDNA] mutator‐prkn/parkin‐KO mice) (Pickrell et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Gautier et al, 2008
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“The recent discovery of recessively inherited loss of function mutations in three distinct genes that are linked to early onset parkinsonism (7–9) has provided a unique opportunity to create in vivo models to identify early pathogenic changes, which may ultimately lead to neurodegeneration (10).”
Self-citationChronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683 · cited 1×
“Accidental exposure to mitochondrial toxins leads to symptoms resembling those of PD via the selective death of dopaminergic neuron (5, 6).”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 1×
“Bioinformatics analysis reveals that PINK1 is a putative serine-threonine kinase with a mitochondrial targeting motif at its N-terminal end (9).”
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · cited 1×
“A growing number of clinical and experimental reports implicate mitochondrial dysfunctions and oxidative stress in the pathogenesis of PD (1, 2).”
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 2×
“In fact, two recent articles showed dramatic functional and structural impairments of mitochondria in Drosophila bearing null mutations for dPINK1 (14, 15).”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 3×
“In fact, two recent articles showed dramatic functional and structural impairments of mitochondria in Drosophila bearing null mutations for dPINK1 (14, 15).”
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Self-citationThe PINK1/Parkin pathway regulates mitochondrial morphology
Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J., & Pallanck, L. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709336105 · Cited by 885 · cited 2×
“How can one explain such a protective role of PINK1 in mitochondria? One possibility, raised by studies in flies, is that PINK1 is involved in the regulation of mitochondrial fission and fusion (16, 17).”
Cited by
Items 501–600 of 722
Wang, H., Wang, Q., Xu, H., Wu, Y., Cheung, S., Xu, Q., Pan, C., Cao, J., Cao, Z., Yang, R., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adp4625 · Cited by 10
Mitochondrial Fission and Fusion
Hewitt, V. L., & Whitworth, A. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00003-1 · Cited by 10
State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons
Basso, V., Döbrössy, M. D., Thompson, L. H., Kirik, D., Fuller, H. R., & Gates, M. A. (2024) · Biology · doi:10.3390/biology13090690 · Cited by 12
“These include models involving α - synuclein ( α -syn) [170], LRRK2 [171–173], PINK1 [174,175], parkin [176], and DJ-1 [177].”
BackgroundInsulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Cardoso, S., Santos, R. X., Correia, S. C., Carvalho, C., Zhu, X., Lee, H., Casadesús, G., Smith, M. A., Perry, G. L., & Moreira, P. I. (2009) · Pharmaceuticals · doi:10.3390/ph2030250 · Cited by 10
“In addition to the defect in mitochondrial complex I, many of the genes involved in PD, such as α-synuclein, parkin, DJ-1, PINK-1 [99-101], LRRK-2 [102,103] and HTRA2 [104,105] have also a direct or indirect effect in mitochondria function.”
BackgroundAnimal models of Parkinson's disease and their applications
Lee, M. K., Park, H. J., & Zhao, T. (2016) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s85419 · Cited by 10
“Similar to parkin knockouts, PINK1 knockout mice do not exhibit any major abnormalities; 77 in particular, the number of dopaminergic neurons and the level of striatal dopamine are unchanged.”
Goldsmith, J., Ordureau, A., Boecker, C. A., Arany, M., Harper, J. W., & Holzbaur, E. L. F. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.03.510717 · Cited by 10
Progress in Parkinson's disease animal models of genetic defects: Characteristics and application
Zhang, C., Chen, S., Li, X., Xu, Q., Lin, Y., Lin, F., Yuan, M., Zi, Y., & Cai, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113768 · Cited by 9
Use of Chemical Probes to Detect Mitochondrial ROS by Flow Cytometry and Spectrofluorometry
Chen, J., & Mathews, C. E. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00012-1 · Cited by 9
Qiao, J., & Mao, Y. (2020) · Invertebrate Neuroscience · doi:10.1007/s10158-020-00244-4 · Cited by 9
Predictors of prodromal Parkinson’s disease in young adult Pink1−/− rats
Lechner, S. A., Welsch, J. M., Pahapill, N. K., Kaldenberg, T. A. R., Regenbaum, A., & Kelm‐Nelson, C. A. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.867958 · Cited by 15
“, 2021) of Pink1−/− male rats as well as in human motor brainstem regions [male and female datasets (GSE19587)] (Gautier et al., 2008; Lewandowski et al., 2010; Diedrich et al., 2011).”
BackgroundPINK1 Loss of Function Selectively Alters the Mitochondrial‐Derived Vesicle Pathway
Collier, C. L., Ruedi, C., Thorne, N. J., & Tumbarello, D. A. (2025) · FASEB BioAdvances · doi:10.1096/fba.2024-00200 · Cited by 8
“In the case of PINK1, its loss of function has been indicated to only mildly alter mitochondrial organization and function in young mice or at steady state, however, mitochondrial organization and function is severely potentiated under stress or during aging [24, 25].”
Beneficial role of capsaicin through modulation of mitochondrial functions in MPTP-injected mice
Tyagi, S., & Thakur, A. K. (2024) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-024-01560-7 · Cited by 8
“Previous reports showed mitochondrial respiration defects in mice brains and linking these recessive PD genes to mitochondrial function gives experimental confirmation to support a causal role of mitochondrial functional damage in PD pathogenesis (Palacino et al. 2004; Gautier et al. 2008).”
Differential distribution of PINK1 and Parkin in the primate brain implies distinct roles
Liu, Y., Huang, W., Wen, J., Xiong, X., Xu, T., Wang, Q., Chen, X., Zhao, X., Li, S., Li, X., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01140 · Cited by 8
“Additionally, the loss of PINK1 has not been found to induce neurodegeneration in mouse and pig brains (Gautier et al., 2008; Kitada et al., 2009; Zhou et al., 2015; Wang et al., 2016).”
BackgroundThapa, K., Khan, H., Chahuan, S., Dhankhar, S., Kaur, A., Garg, N., Saini, M., & Singh, T. G. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10346-0 · Cited by 8
Parkinson's disease and microRNAs - Lessons from model organisms and human studies
Evans, B., Furlong, H. A., & de Lencastre, A. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111585 · Cited by 9
Unravelling the genetic links between Parkinson’s disease and lung cancer
Leong, Y. Q., Koh, R. Y., Chye, S. M., & Ng, K. Y. (2023) · Biological Chemistry · doi:10.1515/hsz-2022-0228 · Cited by 9
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 9
Abubakar, M., Alom, S., Ali, F., Ali, S. R., Adhikary, K., Sarika, S., Gupta, P. K., Puppala, E. R., Murti, K., Nand, S., et al. (2026) · Current Neuropharmacology · doi:10.2174/011570159x446831260303200516 · Cited by 9
“In addition to their roles in the morphological and functional preservation of the mitochondrial network, the removal of damaged mitochondria, a process known as mitophagy, is regulated by parkin and PINK1 [226, 227].”
Mitochondrial dysfunction, iron accumulation, and ferroptosis in Parkinson’s disease
Teferi, N., Challa, M., Woodiwiss, T. R., Allen, B. G., & Petronek, M. S. (2023) · Redox Experimental Medicine · doi:10.1530/rem-23-0004 · Cited by 8
Tian, Z., Zhang, Y., Xu, J., Yang, Q., Hu, D., Feng, J. H., & Gai, C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1451655 · Cited by 9
“…as a pivotal neuroprotective protein, which contribute to prevent mitochondrial dysfunction and activate basal and starvation-induced autophagy (Gautier et al., 2008; Gelmetti et al., 2008; Wood-Kaczmar et al., 2008; Levine et al., 2008), by its interaction with Beclin-1, a key pro-autophagic…”
BackgroundCurrent and Emerging MR Methods and Outcome in Rodent Models of Parkinson’s Disease: A Review
Petiet, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.583678 · Cited by 8
“PINK1 knockout does not produce any DA neuronal depletion in mice, but it alters DA neurotransmission and mitochondrial function (Kitada et al., 2007; Gautier et al., 2008; Gispert et al., 2009).”
BackgroundRejuvenation of the Aging Heart: Molecular Determinants and Applications
Alibhai, F. J., & Li, R. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.03.004 · Cited by 8
Neurodegeneration in Parkinson’s Disease: Genetics Enlightens Physiopathology
Corti, O., Fournier, M., & Brice, A. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_17 · Cited by 7
Sieradzki, A., Yendluri, B. B., Palacios, H. H., Parvathaneni, K., Reddy, V. P., Obrenovich, M. E., Gąsiorowski, K., Leszek, J., & Aliev, G. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794480410 · Cited by 7
“Therefore, PINK1 deficiency causes mitochondrial functional defects and heightens neuron sensitivity to oxidative stress and neurodegeneration [45].”
BackgroundOxidative Stress in Parkinson’s Disease: Role in Neurodegeneration and Targets for Therapeutics
Banerjee, R., Kaidery, N. A., & Thomas, B. (2015) · ACS symposium series · doi:10.1021/bk-2015-1200.ch005 · Cited by 7
Lee, S. H., Lutz, D., Drexler, D., Frotscher, M., & Shen, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240610 · Cited by 9
“Many neurodegenerative diseases, including Huntington’s disease, Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis, involve defects in mitochondrial function and transport [22, 31, 33, 44, 45].”
BackgroundSelf-citationFailure of Diphtheria Toxin Model to Induce Parkinson-Like Behavior in Mice
Valek, L., & Tegeder, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179496 · Cited by 7
Pinizzotto, C. C., Dreyer, K. M., Oluwagbohunmi, A., Caffrey, R. M., Madhira, K., & Kritzer, M. F. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.951268 · Cited by 7
Cheramangalam, R. N., Anand, T., Pandey, P., Balasubramanian, D., Varghese, R., Singhal, N., Nagarkar-Jaiswal, S., & Jaiswal, M. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010493 · Cited by 6
Autophagy and Cellular Senescence in Lung Diseases
Kuwano, K., Araya, J., Hara, H., Minagawa, S., Takasaka, N., Ito, S., & Nakayama, K. (2015) · Journal of Biochemistry and Molecular Biology Research · doi:10.17554/j.issn.2313-7177.2015.01.5 · Cited by 6
Ulusoy, A., & Kirik, D. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.95 · Cited by 7
Zhang, Y., Hu, H.-T., Cao, Y.-M., Jiang, Z.-G., Liu, J., & Fan, Q. (2023) · Dose-Response · doi:10.1177/15593258231169392 · Cited by 6
“Fluorescence probes were used to detect intracellular concentration of ROS.”
BackgroundInfluentialLiu, T. T., Pascal, L. E., Bauer, S. R., Miles, H. N., Panksepp, J. B., Lloyd, G. L., Li, L., DeFranco, D. B., & Ricke, W. A. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae007 · Cited by 6
Karki, R., Kodamullil, A. T., Hoyt, C. T., & Hofmann‐Apitius, M. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3101-1 · Cited by 6
King, L., & Plun‐Favreau, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00005-5 · Cited by 7
Nitrooxidative Stress and Neurodegeneration
Fiedorowicz, M., & Grieb, P. (2012) · InTech eBooks · doi:10.5772/37733 · Cited by 6
“…Calcium antagonists - Anti-inflammatory drugs Downstream antioxidants Scavenging free radicals (direct antioxidants) - Tocopherols - Flavonoids - Selenium-containigs compounds (e.g. ebselen) - Polyenes (carotene, lycopene, retinol) Catalizing decomposition of free radicals - Mimetics of…”
BackgroundQiao, Y., Kou, J., Tian, Y., Ma, W., Yu, Y., Pang, J., Pei, Y., Zhang, Y., Ye, B., Xie, Z., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107773 · Cited by 5
“Mice that lack PINK1 show reduced levels of respiration in mitochondria, along with being more susceptible to the toxic effects of oxidative stress and increased mitochondrial dysfunction (15, 16).”
BackgroundNIPSNAP1 and NIPSNAP2 facilitate healthy aging independent of mitophagy
Lv, J., Wang, J., Chen, Q., Zhong, Q., Zhan, H., Guo, Q., Li, J., Guo, N., Yu, F., Tong, J., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156324 · Cited by 5
Ji, X., Zhang, X., Zhang, T., Yao, X., He, M., Li, C., Huang, Y. L., Wang, H., Ju, J., Cai, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61904-w · Cited by 5
“PINK1/Parkin-mediated mitophagy is a widely characterized ubiquitin-dependent mitophagy pathway 31,32 , while NIX/BNIP3L and FUNDC1 contribute to Receptor-mediated mitophagy 33 – 36 .”
Schmidt, M. Y., Cuervo, A. M., Double, K. S., Ehninger, D., Goldberg, M. S., Harvey, K., Hoeijmakers, J. H. J., Luk, K. C., Mastroberardino, P. G., Moore, D. J., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01239-x · Cited by 5
Diagnostics, rehabilitation and models of Parkinson’s disease
Dushanova, J. (2012) · Health · doi:10.4236/health.2012.431178 · Cited by 5
“The next review [147-156] focused on animal models of both toxin-induced and genetically determined PD that have provided significant insight for understanding this disease, and also discussed the validity, benefits, and limitations of representative models.”
BackgroundNon-mammalian animal models of Parkinson's disease for drug discovery
Lim, K. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903527675 · Cited by 5
Mitochondrial dysfunction in Parkinson’s disease: a possible target for neuroprotection
Gleave, J. A., Perri, P. D., & Nash, J. E. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1337-8 · Cited by 5
“Loss of PINK1 also affects the normal function of the mitochondria in mice (Gautier et al., 2008; Gispert et al., 2009).”
InfluentialChen, K. G., & Calderone, R. (2016) · Current cancer research · doi:10.1007/978-3-319-42740-9_6 · Cited by 5
Role of Oxidative Stress in Human Neurodegenerative Pathologies: Lessons from the Drosophila Model
Bolshakova, O. I., Golomidov, I. M., Latypova, E. M., Ryabova, E. V., & Sarantseva, S. V. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266356916250729040245 · Cited by 4
Alhegaili, A. S., Bafail, D. A., Bawahab, A. A., Alsubaie, N., Abd‐Elhakim, Y. M., Mohamed, A. A.-R., Khamis, T., Khalifa, N. E., Elhamouly, M., Dahran, N. A., et al. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.115095 · Cited by 4
Various zebrafish models of Parkinson's disease: What gives us hope
Wadan, A. S., & Mohamed, W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16128-5.00013-x · Cited by 4
PINK1: One Protein, Multiple Neuroprotective Functions
Valente, E. M., Michiorri, S., Arena, G., & Gelmetti, V. (2009) · Future Neurology · doi:10.2217/fnl.09.39 · Cited by 4
Deng, I. B., Garg, S., Zhou, X., & Bobrovskaya, L. (2022) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1402013 · Cited by 6
“Mitophagy can be initiated in a PINK1/parkin-dependent manner, and deletion in these proteins in mice results in impaired mitochondrial biogenesis and respiration, increased sensitivity to oxidative stress, and reduced synaptic excitability [44– 46].”
BackgroundMitochondrial Dysfunction and Molecular Bases of Neurodegenerative Diseases
Kolesnikova, E. E. (2013) · Neurophysiology · doi:10.1007/s11062-013-9341-1 · Cited by 4
“neocortex; this was indicative of certain specificity of manifestations of such defect for dopaminergic neurons [21].”
BackgroundWang, Y., Li, S., Liu, M., Wang, J., Fei, Z., Wang, F., Jiang, Z., Huang, W., & Sun, H. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.036 · Cited by 4
Chang, J., Chang, H.-S., Chao, Y., Huang, C., Lin, C., Lin, C.-H., Wu, Z.-S., Chang, H., Liu, C.-S., & Chuang, C. (2024) · Biology · doi:10.3390/biology13040231 · Cited by 4
“Loss of Pink1 impairs mitochondrial function, leading to mitochondrial dysfunction, increases oxidative stress, and compromises cellular energy production [47].”
BackgroundPARKIN/PINK1 Pathway for the Selective Isolation and Degradation of Impaired Mitochondria
Narendra, D. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_8 · Cited by 6
Beier, E. E., & Richardson, J. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00013-3 · Cited by 4
Li, X., Zhang, W., Zhang, C., Yi, Z., Zhang, D., Gong, W., Tang, J., Wang, D., Lu, W., Chen, X., et al. (2014) · Molecular Genetics and Genomics · doi:10.1007/s00438-014-0942-1 · Cited by 4
“PINK1 knockout mice exhibited impaired mitochondrial respiration and increased sensitivity to oxidative stress (Gautier et al. 2008).”
BackgroundFrison, M., Mallach, A., Kennedy, E., & Campanella, M. (2017) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-319-55539-3_11 · Cited by 5
Luz, A. L., Rooney, J. P., Kubik, L. L., Gonzalez, C. P., Song, D. H., & Meyer, J. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168738 · Cited by 4
Ahmad, B., Dumbuya, J. S., Tang, J., Li, W., Chen, X., & Lu, J. (2025) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2025.108553 · Cited by 4
Keleş, B. S., Rumman, B., Samarie, M. A. J. A., Özdemir, Y., Çakmak, Ö. Ö., Akyoldaş, G., Ertan, S., & Sokullu, E. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02461-z · Cited by 4
“Loss of PINK1 leads to enlarged, dysfunctional mitochondria in the striatum and subsequent mitochondrial-respiration failure in the cerebral cortex of mouse models [83].”
Verbal, F., Espinoza-Rubilar, N., Marileo, A. M., Fierro, H., Ramírez-Molina, O., Pinto-León, A., Yévenes, G. E., Fuentealba, J., & Panes-Fernández, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1723748 · Cited by 3
Mitochondrial dysfunction in follicles is associated with broodiness in Zhedong white goose
Yu, J. H., & Guo, C. (2022) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2022.107032 · Cited by 3
The PINK1/Parkin pathway of mitophagy exerts a protective effect during prion disease
Ward, A. E., Jessop, F., Faris, R., Hollister, J. R., Shoup, D. W., Race, B., Bosio, C. M., & Priola, S. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298095 · Cited by 3
Aerts, L., & Morais, V. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00002-x · Cited by 3
Genes involved in the development of Parkinson
Teixeira, D., & Cardoso, I. (2017) · Open Journal of Parkinson s Disease and Treatment · doi:10.17352/ojpdt.000005 · Cited by 3
“Mice having this gene defi cient show problems in production and release of dopamine [30], altered mitochondrial respiration and increased sensitivity to oxidative stress [31].”
BackgroundMartinez‐Finley, E. J., Chakraborty, S., Caito, S., Fretham, S. J. B., & Aschner, M. (2012) · PubMed · Cited by 4
PINK1 (PARK6) and Parkinson's Disease
Valente, E. M., & Ferraris, A. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00005-2 · Cited by 4
Aliev, G., Burzynski, G. S., Ashraf, G. M., Jabir, N. R., Cacabelos, R., Benberin, V. V., & Burzynski, S. R. (2011) · Springer eBooks · doi:10.1007/978-3-642-30018-9_206 · Cited by 4
“Therefore, PINK1 deficiency causes mitochondrial functional defects and heightens neuron sensitivity to oxidative stress and neurodegeneration (Gautier et al. 2008).”
BackgroundEtiology and pathogenesis of Parkinson’s disease: role of mitochondrial pathology
Brini, M., Ottolini, & Calí, T. (2013) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s28413 · Cited by 6
“9,11,44 No differences were instead observed in the expression levels of the subunits of the respiratory chain complexes.”
Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice
Zhi, L., Zhao, J., Jaffe, D. E., Chen, Y., Wang, N., Qin, Q., Seifert, E. L., Li, C., & Zhang, H. (2022) · Journal of Visualized Experiments · doi:10.3791/63379 · Cited by 3
Zebrafish as a model of Parkinson's disease
Sallinen, V. J. (2009) · Helda - University of Helsinki Institutional Repository · Cited by 5
PINK1 Regulates Dopamine and Lipids at Mitochondria to Maintain Synapses and Neuronal FunctionPreprint
Bus, C., Geisler, S., Feldkaemper, M. P., Flores‐Romero, H., Schaedler, A., Zittlau, K. I., Zarani, M., Uysal, B., Casadei, N., Fallier‐Becker, P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/814343 · Cited by 3
“2006 Apr 11;66(7):1129-30; author reply -30.”
MethodECSIT prevents Alzheimer’s disease pathology by regulating neuronal mitochondrial ROS and mitophagyPreprint
Lepelley, A., Vaughn, L. S., Staniszewski, A., Zhang, H., Du, F., Koppensteiner, P., Tomljanovic, Z., Carneiro, F. R. G., Teich, A. F., Ninan, I., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.09.900407 · Cited by 4
Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2
“However, when PINK1 is mutated, it loses its function, which means there is no longer any protection against ROS [141].”
Targeting TLR4 in Parkinson's disease: mechanisms and therapeutic prospects
Dong, S., Lu, J., Wu, L., Wang, S., 宫玉波, Hu, J., Liu, Y., & Chen, X. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116780 · Cited by 2
Zhang, X., Liu, X., Qiao, Y., Rabata, A., Liu, N., Yao, C., Parimon, T., Chen, D., Hogaboam, C. M., Chen, P., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci198031 · Cited by 4
“Expression of oxidative stress–response proteins is reduced in IPF epithelial cells (53–55), and the ensuing loss of cellular redox homeostasis has been suggested to be a fundamental driver of IPF pathogenesis for decades (51, 88).”
Mitophagy in cisplatin-induced kidney injury: regulatory mechanisms and therapeutic targets
Yuan, C., Jiang, J., Ji, J., & Ni, L. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2672141 · Cited by 2
“Lack of PINK1 exacerbates mitochondrial dysfunction, impairing mitochondrial function and increasing sensitivity to oxidative stress [67].”
The young-onset Parkinson disease
HUANG, Y., Chen, Y., Lin, Y., Lin, Z., Yang, M., Zhang, J., Shi, Q., & Mianmian, X. U. (2022) · Minerva Medica · doi:10.23736/s0026-4806.22.08421-x · Cited by 2
The Potential of Targeting LRRK2 in Parkinson’s Disease
Ho, F. Y., Rosenbusch, K. E., & Kortholt, A. (2014) · InTech eBooks · doi:10.5772/57362 · Cited by 3
“PTEN-induced kinase 1 (PINK1) is important for mitochondrial function and its deletion leads to increased suscept‐ ibility to oxidative stress [83, 84].”
BackgroundNorazit, A., Mellick, G. D., & Meedeniy, A. C. B. (2012) · InTech eBooks · doi:10.5772/33459 · Cited by 2
“The lack of PINK1 in transgenic mice causes enlargement of mitochondria as well as a decrease in mitochondrial numbers in dopaminergic neurons of the nigrostriatal pathway (Gautier et al. 2008, Gispert et al. 2009, Kitada et al. 2007).”
TIGARB CAUSES MITOCHONDRIAL DYSFUNCTION AND NEURONAL LOSS IN PINK1 DEFICIENCY
Bandmann, O. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306573.16 · Cited by 2
Rodent Models of Autosomal Recessive Parkinson Disease
Gispert, S., Auburger, G. W. J., Kuruvilla, K. P., & LeDoux, M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00019-6 · Cited by 3
Loss of PINK1 or Parkin Function Results in a Progressive Loss of Mitochondrial Function
Taanman, J., & Protasoni, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812146-7.00007-x · Cited by 2
Environmental Stress: Mitochondria as Targets and Stressors in Cellular Metabolism
Bereiter‐Hahn, J., & Jendrach, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-16996-1_5 · Cited by 2
The role of the E3 ubiquitin ligase FBXO7-SCF in early-onset Parkinson's disease
Brockelt, D. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5833 · Cited by 2
Kim, Y. Y., Yoon, J.-H., Um, J., Jeong, D. J., Shin, D. J., Hong, Y. B., Kim, J. K., Kim, D. H., Kim, C., Chung, C. G., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257439 · Cited by 2
Wang, H., Chen, R., Xiao, L., Kumar, M., Acevedo-Cintrón, J. A., Siuda, J. S., Koziorowski, D., Wszołek, Z. K., Dawson, V. L., & Dawson, T. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.23.546087 · Cited by 5
“In contrast, in PINK1 and PARKIN mutant files [41], in PINK knockout mice [42] mitochondrial do not accumulate.”
The Role of Autophagy and Mitophagy in Mitochondrial Diseases
Paz, M. V., Cotán, D., Cordero, M. D., Garrido‐Maraver, J., Oropesa-Ávila, M., de la Mata, M., Pavón, A. D., Alcocer‐Gómez, E., de Lavera, I., & Alcázar, J. A. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802937-4.00008-9 · Cited by 4
Peng, W., Guo, Y., Wu, X., Miao, L., & Zhou, X. (2025) · Animals · doi:10.3390/ani15233465 · Cited by 1
Chenna, S., Joselin, A. P., Theurey, P., Bano, D., Pizzo, P., Ankarcrona, M., Park, D. S., Prehn, J. H. M., & Connolly, N. M. C. (2026) · PLoS ONE · doi:10.1371/journal.pone.0339326 · Cited by 1
Xia, L., Liu, T., Li, Z., Ao, X., Chen, Q., Zhou, X., Jiang, Q., Huang, N., & Luo, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1741339 · Cited by 1
Montanari, M., Balsamo, F., Ponterio, G., Atiallah, I. E., Landolfo, E., Berretta, E., D’Ambra, C., Martella, G., Meringolo, M., Tassone, A., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106557 · Cited by 1
Rawi, S. A., Tyers, P., Barker, R. A., & Laman, H. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02294-y · Cited by 1
Mitochondria: The Crossroads of Complement Activation and Kidney Injury Progression
McGraw, M. K., & Parajuli, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125599 · Cited by 1
6Chapter Micronutrients for the Prevention of Diabetes and Improvement of the Standard Therapy
Prasad, K. N. (2010) · CRC Press eBooks · doi:10.1201/ebk1439821060-11 · Cited by 1
Mitochondrial Fission-Fusion and Parkinson’s Disease: A Dynamic Question of Compensatory Networks
Chu, C. T., & Berman, S. (2011) · Springer eBooks · doi:10.1007/978-94-007-1291-1_7 · Cited by 2
“Mitochondrial morphology is dramatically altered in Drosophila and mammalian culture models of PINK1 deficiency, while mouse models show much more subtle morphologic effects (Gispert et al. 2009; Gautier et al. 2008).”
BackgroundAnimal Models of Parkinson’s Disease Induced by Toxins and Genetic Manipulation
Hisahara, S., & Shimoham, S. (2012) · InTech eBooks · doi:10.5772/19860 · Cited by 1
Micronutrients for the Prevention and Improvement of the Standard Therapy for Parkinson’s Disease
Prasad, K. N. (2019) · CRC Press eBooks · doi:10.1201/9780429243462-10 · Cited by 1
Beilina, A. G., & Cookson, M. (2012) · Neuromethods · doi:10.1007/978-1-61779-824-5_12 · Cited by 1
Haddad, D., & Verstreken, P. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch4 · Cited by 1
Kuwano, K., Araya, J., Hara, H., Minagawa, S., Takasaka, N., Ito, S., & Nakayama, K. (2016) · Respiratory disease series · doi:10.1007/978-981-10-0839-9_6 · Cited by 3
Metadata
- Authors
- Gautier, C. A., Kitada, T., & Shen, J.
- Affiliations
- Center for Neurologic Diseases, Brigham and Women's Hospital, Program in Neuroscience, Harvard Medical School, Boston, MA 02115
- Brigham and Women's Hospital (US)
- ORCID
- Shen, Jie
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-08-12
- Volume
- 105
- Issue
- 32
- Pages
- 11364-11369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2516271
- OpenAlex
- W1990287702
- Cited by
- 698
- References
- 39
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 24 · 2023: 29 · 2022: 37 · 2021: 32 · 2020: 48 · 2019: 30 · 2018: 36 · 2017: 33 · 2016: 49 · 2015: 37 · 2014: 46 · 2013: 45 · 2012: 53
- FWCI
- 34.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts Institute of Technology
- National Institute of Neurological Disorders and Stroke (R01NS041779, R01 NS41779)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, Parkinson's disease, mitochondrial dysfunction, mitochondrial respiration, oxidative stress, aconitase, striatum, cerebral cortex, nigrostriatal degeneration, dopaminergic neurons, aging, heat shock, hydrogen peroxide, TCA cycle
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Cerebral Cortex, Citric Acid Cycle, Corpus Striatum, Hydrogen Peroxide, Mitochondria, Oxygen Consumption, Parkinson Disease, Protein Kinases, Time Factors, Gene Deletion, Germ-Line Mutation, Mice, Knockout, Oxidative Stress, Heat-Shock Response, Mitochondrial Proteins, Mitochondrial Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.